Year: 2026
Type: review
Abstract: , antibodies, nanobodies, or affimers). Emerging approaches also employ peptides, proteins, nucleic acid aptamers, and small molecules as low-affinity ligands. Low-affinity labelling already enables imaging with resolution down to ∼1 nm, but it remains rather slow and mainly compatible with fixed cells. We anticipate that this field will continue to expand rapidly, driven on the one hand by new concepts in fluorogenic dye design and reversible labelling strategies and, on the other hand, by the growing range of applications in advanced fluorescence microscopy.
Source: Chemical Science
DOI: 10.1039/d6sc05417j
Language: English
Subfield: Biophysics
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7223171846
